Physician profile

Long-Chau Van

Pain Medicine (Anesthesiology) · Springfield, MA

NPI 1699160259

$1,656.10

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$234.02
Education$19.81

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic USA, INC. $668.02 2019
Pacira Pharmaceuticals Incorporated $566.09 2022
Spr Therapeutics, INC $141.72 2021
Medtronic, INC. $127.79 2023 Intellis Adaptivestim
Vertos Medical, INC. $106.23 2024 Mild Device Kit
Csl Behring $26.44 2020
Merck Sharp & Dohme LLC $19.81 2023 Bridion

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Long-Chau Van

$1,656.10

in general payments reported 2019-2025

Years
2019-2024
Top company
Medtronic USA, INC.

https://glasscript.com/doctor/7226811/long-chau-van

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.